{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:19:36Z","timestamp":1786119576879,"version":"build-2736575974"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1097\/hjh.0b013e328341cedf","type":"journal-article","created":{"date-parts":[[2010,11,30]],"date-time":"2010-11-30T08:02:11Z","timestamp":1291104131000},"page":"542-552","source":"Crossref","is-referenced-by-count":23,"title":["Inhibition of mineralocorticoid receptor is a renoprotective effect of the 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor pitavastatin"],"prefix":"10.1097","volume":"29","author":[{"given":"Xian Wu","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Kuzuya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiko","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haizhen","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyosuke","family":"Takeshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Hirashiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohji","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Ping","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Okumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toyoaki","family":"Murohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-21-20210208","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1056\/NEJMe020054","article-title":"Hypertension, angiotensin II, and oxidative stress","volume":"346","author":"Sowers","year":"2002","journal-title":"N Engl J Med"},{"key":"R2-21-20210208","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1161\/01.RES.0000261657.76299.ff","article-title":"Critical role of the NAD(P)H oxidase subunit p47phox for left ventricular remodeling\/dysfunction and survival after myocardial infarction","volume":"100","author":"Doerries","year":"2007","journal-title":"Circ Res"},{"key":"R3-21-20210208","doi-asserted-by":"crossref","first-page":"358","DOI":"10.2353\/ajpath.2008.071126","article-title":"Superoxide-dependent cathepsin activation is associated with hypertensive myocardial remodeling and represents a target for angiotensin II type 1 receptor blocker treatment","volume":"173","author":"Cheng","year":"2008","journal-title":"Am J Pathol"},{"key":"R4-21-20210208","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/FJC.0b013e3181ab371d","article-title":"Mechanism of diastolic stiffening of the failing myocardium and its prevention by angiotensin receptor and calcium channel blockers","volume":"54","author":"Cheng","year":"2009","journal-title":"J Cardiovasc Pharmacol"},{"key":"R5-21-20210208","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1161\/01.HYP.0000255636.11931.a2","article-title":"Podocyte as the target for aldosterone: roles of oxidative stress and Sgk1","volume":"49","author":"Shibata","year":"2007","journal-title":"Hypertension"},{"key":"R6-21-20210208","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1161\/01.HYP.0000203772.78696.67","article-title":"Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and failure in low-aldosterone hypertensive rats","volume":"47","author":"Nagata","year":"2006","journal-title":"Hypertension"},{"key":"R7-21-20210208","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1161\/01.RES.73.3.413","article-title":"Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype","volume":"73","author":"Sadoshima","year":"1993","journal-title":"Circ Res"},{"key":"R8-21-20210208","doi-asserted-by":"crossref","first-page":"38911","DOI":"10.1074\/jbc.M103984200","article-title":"Alteration of cardiac and renal functions in transgenic mice overexpressing human mineralocorticoid receptor","volume":"276","author":"Le Menuet","year":"2001","journal-title":"J Biol Chem"},{"key":"R9-21-20210208","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1056\/NEJM200109203451215","article-title":"Spironolactone in addition to ACE inhibition to reduce proteinuria in patients with chronic renal disease","volume":"345","author":"Chrysostomou","year":"2001","journal-title":"N Engl J Med"},{"key":"R10-21-20210208","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1210\/mend.13.1.0226","article-title":"Modulation of human mineralocorticoid receptor function by protein kinase A","volume":"13","author":"Massaad","year":"1999","journal-title":"Mol Endocrinol"},{"key":"R11-21-20210208","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1056\/NEJM199811123392007","article-title":"Pathophysiology of progressive nephropathies","volume":"339","author":"Remuzzi","year":"1998","journal-title":"N Engl J Med"},{"key":"R12-21-20210208","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med"},{"key":"R13-21-20210208","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/0002-8703(84)90763-4","article-title":"The prognostic significance of proteinuria: the Framingham study","volume":"108","author":"Kannel","year":"1984","journal-title":"Am Heart J"},{"key":"R14-21-20210208","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1159\/000091956","article-title":"Effect of pitavastatin on urinary liver-type fatty-acid-binding protein in patients with nondiabetic mild chronic kidney disease","volume":"26","author":"Nakamura","year":"2006","journal-title":"Am J Nephrol"},{"key":"R15-21-20210208","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1161\/CIRCRESAHA.107.163493","article-title":"Pitavastatin, an HMG-CoA reductase inhibitor, exerts eNOS-independent protective actions against angiotensin II induced cardiovascular remodeling and renal insufficiency","volume":"102","author":"Yagi","year":"2008","journal-title":"Circ Res"},{"key":"R16-21-20210208","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1161\/01.HYP.0000024348.87637.6F","article-title":"Simvastatin prevents angiotensin II-induced cardiac alteration and oxidative stress","volume":"40","author":"Delbosc","year":"2002","journal-title":"Hypertension"},{"key":"R17-21-20210208","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1161\/01.CIR.0000084539.58092.DE","article-title":"Short-term statin therapy improves cardiac function and symptoms in patients with idiopathic dilated cardiomyopathy","volume":"108","author":"Node","year":"2003","journal-title":"Circulation"},{"key":"R18-21-20210208","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/jcb.10602","article-title":"Pitavastatin alters the expression of thrombotic and fibrinolytic proteins in human vascular cells","volume":"90","author":"Markle","year":"2003","journal-title":"J Cell Biochem"},{"key":"R19-21-20210208","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1161\/01.ATV.0000060461.64771.F0","article-title":"Pitavastatin-induced thrombomodulin expression by endothelial cells acts via inhibition of small G proteins of the Rho family","volume":"23","author":"Masamura","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R20-21-20210208","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/nm.1879","article-title":"Modification of mineralocorticoid receptor function by Rac1 GTPase: implication in proteinuric kidney disease","volume":"14","author":"Shibata","year":"2008","journal-title":"Nat Med"},{"key":"R21-21-20210208","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1161\/01.HYP.0000242331.99369.2f","article-title":"An elastolytic cathepsin induction\/activation system exists in the rat and human myocardium and is upregulated in hypertensive heart failure","volume":"48","author":"Cheng","year":"2006","journal-title":"Hypertension"},{"key":"R22-21-20210208","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1161\/01.HYP.0000222003.28517.99","article-title":"Podocyte injury underlies the glomerulopathy of Dahl salt-hypertensive rats and is reversed by aldosterone blocker","volume":"47","author":"Nagase","year":"2006","journal-title":"Hypertension"},{"key":"R23-21-20210208","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1097\/01.fjc.0000211791.22411.0d","article-title":"Pitavastatin improves cardiac function and survival in association with suppression of the myocardial endothelin system in a rat model of hypertensive heart failure","volume":"47","author":"Saka","year":"2006","journal-title":"J Cardiovasc Pharmacol"},{"key":"R24-21-20210208","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.2337\/diabetes.52.4.1023","article-title":"Nephrin expression is reduced in human diabetic nephropathy: evidence for a distinct role for glycated albumin and angiotensin II","volume":"52","author":"Doublier","year":"2003","journal-title":"Diabetes"},{"key":"R25-21-20210208","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.cardiores.2005.08.001","article-title":"Pravastatin increases survival and suppresses an increase in myocardial matrix metalloproteinase activity in a rat model of heart failure","volume":"69","author":"Ichihara","year":"2006","journal-title":"Cardiovasc Res"},{"key":"R26-21-20210208","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1161\/01.RES.0000159937.05502.d1","article-title":"Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells","volume":"96","author":"Jaffe","year":"2005","journal-title":"Circ Res"},{"key":"R27-21-20210208","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1161\/01.CIR.102.11.1315","article-title":"Monocyte chemoattractant protein-1 is upregulated in rats with volume-overload congestive heart failure","volume":"102","author":"Behr","year":"2000","journal-title":"Circulation"}],"container-title":["Journal of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/HJH.0b013e328341cedf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:37:23Z","timestamp":1786041443000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004872-201103000-00021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/hjh.0b013e328341cedf","relation":{},"ISSN":["0263-6352"],"issn-type":[{"value":"0263-6352","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}